Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
221.55
-7.03 (-3.08%)
At close: Jul 11, 2025, 4:00 PM
221.39
-0.16 (-0.07%)
After-hours: Jul 11, 2025, 7:54 PM EDT
Molina Healthcare Stock Forecast
Stock Price Forecast
The 16 analysts that cover Molina Healthcare stock have a consensus rating of "Buy" and an average price target of $350.53, which forecasts a 58.22% increase in the stock price over the next year. The lowest target is $266 and the highest is $414.
Price Target: $350.53 (+58.22%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Molina Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 5 | 5 | 5 | 6 | 4 |
| Hold | 8 | 7 | 9 | 9 | 9 | 10 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 16 | 16 | 17 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $400 → $330 | Buy | Maintains | $400 → $330 | +48.95% | Jul 11, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $364 → $266 | Buy → Hold | Downgrades | $364 → $266 | +20.06% | Jul 10, 2025 |
| Barclays | Barclays | Hold Maintains $351 → $347 | Hold | Maintains | $351 → $347 | +56.62% | Jun 9, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $364 | Buy | Initiates | $364 | +64.30% | Jun 9, 2025 |
| Barclays | Barclays | Hold Maintains $362 → $351 | Hold | Maintains | $362 → $351 | +58.43% | Jun 2, 2025 |
Financial Forecast
Revenue This Year
44.61B
from 39.16B
Increased by 13.91%
Revenue Next Year
48.25B
from 44.61B
Increased by 8.14%
EPS This Year
23.85
from 20.42
Increased by 16.78%
EPS Next Year
27.44
from 23.85
Increased by 15.08%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 47.1B | 51.5B | 54.9B | ||
| Avg | 44.6B | 48.2B | 51.4B | ||
| Low | 42.7B | 44.9B | 48.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.2% | 15.4% | 13.8% | ||
| Avg | 13.9% | 8.1% | 6.5% | ||
| Low | 9.2% | 0.6% | -0.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 25.84 | 32.55 | 37.38 | ||
| Avg | 23.85 | 27.44 | 31.27 | ||
| Low | 21.32 | 23.03 | 26.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.5% | 36.5% | 36.2% | ||
| Avg | 16.8% | 15.1% | 13.9% | ||
| Low | 4.4% | -3.4% | -2.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.